Acceleron Pharma (XLRN) Stock Cash Flow
NASDAQ:XLRN - Nasdaq -
| TTM (2021-9-30) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -254.85M | -166.03M | -124.86M | -118.87M | -108.45M | |||
| Depreciation Amortization | 4.23M | 3.85M | 3.94M | 3.75M | 2.83M | |||
| Change In Working Capital | -57.19M | 240.00K | 3.99M | -4.56M | -330.00K | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 46.46M | 31.62M | 23.12M | 24.98M | 29.42M | |||
| OPERATING CASH FLOW | -261.36M | -130.33M | -93.80M | -94.71M | -76.54M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -5.20M | -4.20M | -3.29M | -2.59M | -4.40M | |||
| Other Investing Activity | -155.96M | 29.80M | -68.00M | 125.52M | -59.97M | |||
| INVESTING CASH FLOW | -161.16M | 25.60M | -71.29M | 122.93M | -64.37M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 0.00 | -140.00K | 0.00 | |||
| Stock Issued/Repurchased | 29.09M | 538.01M | 258.72M | 17.02M | 220.52M | |||
| Other Financing Activity | N/A | N/A | N/A | -730.00K | -230.00K | |||
| FINANCING CASH FLOW | 29.09M | 538.01M | 258.72M | 16.15M | 220.30M | |||
| CHANGE IN CASH | -393.43M | 433.28M | 93.63M | 44.37M | 79.39M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -261.36M | -130.33M | -93.80M | -94.71M | -76.54M | |||
| Capital Expenditure | -5.20M | -4.20M | -3.29M | -2.59M | -4.40M | |||
| FREE CASH FLOW | -266.56M | -134.53M | -97.09M | -97.30M | -80.94M | |||
All data in USD